Matthew B. Klein - CHIEF EXECUTIVE OFFICER, Director at PTC THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
PTCT on Nasdaq
All Insider Reports
All Insider Reports

Matthew B. Klein - trading volume in the past year for PTC THERAPEUTICS, INC.

Holdings reported by Matthew B. Klein for PTC THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 387,082 $26,848,007 $69.36 18 Feb 2026 Direct
Stock Option (Right to Buy) 157,500 $4,733,750 $27.05 02 Jan 2026 Direct Common Stock

Transactions reported by Matthew B. Klein for PTC THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.